Loading…
Optimized double emulsion-solvent evaporation process for production of solid lipid nanoparticles containing baclofene as a lipid insoluble drug
Intrathecal injection of baclofen is the reference treatment for severe spasticity of cerebral-spinal origin. Solid lipid nanoparticles (SLNs) could be considered as a beneficial delivery system for enhancing penetration of drug through the blood brain barrier (BBB). In this study, baclofen- loaded...
Saved in:
Published in: | Journal of drug delivery science and technology 2013-01, Vol.23 (3), p.225-230 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c342t-f9042d626dfe69ccde012a5288cb692aa710142c372985da53e7f06155664ec3 |
---|---|
cites | cdi_FETCH-LOGICAL-c342t-f9042d626dfe69ccde012a5288cb692aa710142c372985da53e7f06155664ec3 |
container_end_page | 230 |
container_issue | 3 |
container_start_page | 225 |
container_title | Journal of drug delivery science and technology |
container_volume | 23 |
creator | Nabi-Meibodi, M. Navidi, B. Navidi, N. Vatanara, A. Reza Rouini, M. Ramezani, V. |
description | Intrathecal injection of baclofen is the reference treatment for severe spasticity of cerebral-spinal origin. Solid lipid nanoparticles (SLNs) could be considered as a beneficial delivery system for enhancing penetration of drug through the blood brain barrier (BBB). In this study, baclofen- loaded SLNs were prepared using double emulsification-solvent evaporation method and a Box-Behnken design, based on three independent variables, was used to reduce the number of required experiments. Variable parameters were drug/lipid ratio, w/o phase ratio and the amount of surfactant. It was deduced that SLNs with small particle size, lipophilic feature, high entrapment efficiency and good loading capacity could be produced by this method and experimental design method could be useful for predicting optimum baclofen loaded SLNs with minimum numbers of experiments. Characterization of optimum formulation, provided by evaluation of experimental data, showed no significant difference between calculated and measured data. |
doi_str_mv | 10.1016/S1773-2247(13)50034-7 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1412518552</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1773224713500347</els_id><sourcerecordid>1412518552</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342t-f9042d626dfe69ccde012a5288cb692aa710142c372985da53e7f06155664ec3</originalsourceid><addsrcrecordid>eNqFUMtqwzAQ9KGFhjSfUNAxPbjVw7LsUymhLwjk0NyFIq2Diiy5kh1ov6KfXMcJvfayuwwzs8xk2Q3BdwST8v6dCMFySguxJOyWY8yKXFxksz_4Kluk9IExJgKTgtaz7GfT9ba132CQCcPOAYJ2cMkGn6fgDuB7BAfVhaj6EUNdDBpSQk2Ix9sMeoJDg0a2NcjZbpxe-dCp2FvtICEdfK-st36Pdkq70IAHpBJSZ7b1o3Z6beKwv84uG-USLM57nm2fn7ar13y9eXlbPa5zzQra502NC2pKWpoGylprA5hQxWlV6V1ZU6UEOSbUTNC64kZxBqLBJeG8LAvQbJ4tT7Zjis8BUi9bmzQ4pzyEIUlSEMpJxTkdqfxE1TGkFKGRXbStil-SYHnsXU69y2PBkjA59S7FqHs46WCMcbAQZdIWvAZjI-hemmD_cfgFF_2Ppg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1412518552</pqid></control><display><type>article</type><title>Optimized double emulsion-solvent evaporation process for production of solid lipid nanoparticles containing baclofene as a lipid insoluble drug</title><source>ScienceDirect Freedom Collection</source><creator>Nabi-Meibodi, M. ; Navidi, B. ; Navidi, N. ; Vatanara, A. ; Reza Rouini, M. ; Ramezani, V.</creator><creatorcontrib>Nabi-Meibodi, M. ; Navidi, B. ; Navidi, N. ; Vatanara, A. ; Reza Rouini, M. ; Ramezani, V.</creatorcontrib><description>Intrathecal injection of baclofen is the reference treatment for severe spasticity of cerebral-spinal origin. Solid lipid nanoparticles (SLNs) could be considered as a beneficial delivery system for enhancing penetration of drug through the blood brain barrier (BBB). In this study, baclofen- loaded SLNs were prepared using double emulsification-solvent evaporation method and a Box-Behnken design, based on three independent variables, was used to reduce the number of required experiments. Variable parameters were drug/lipid ratio, w/o phase ratio and the amount of surfactant. It was deduced that SLNs with small particle size, lipophilic feature, high entrapment efficiency and good loading capacity could be produced by this method and experimental design method could be useful for predicting optimum baclofen loaded SLNs with minimum numbers of experiments. Characterization of optimum formulation, provided by evaluation of experimental data, showed no significant difference between calculated and measured data.</description><identifier>ISSN: 1773-2247</identifier><identifier>DOI: 10.1016/S1773-2247(13)50034-7</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Baclofen ; Double emulsion ; Entrapment efficiency ; Optimization ; Solid lipid nanoparticles ; solvent evaporation</subject><ispartof>Journal of drug delivery science and technology, 2013-01, Vol.23 (3), p.225-230</ispartof><rights>2013 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c342t-f9042d626dfe69ccde012a5288cb692aa710142c372985da53e7f06155664ec3</citedby><cites>FETCH-LOGICAL-c342t-f9042d626dfe69ccde012a5288cb692aa710142c372985da53e7f06155664ec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Nabi-Meibodi, M.</creatorcontrib><creatorcontrib>Navidi, B.</creatorcontrib><creatorcontrib>Navidi, N.</creatorcontrib><creatorcontrib>Vatanara, A.</creatorcontrib><creatorcontrib>Reza Rouini, M.</creatorcontrib><creatorcontrib>Ramezani, V.</creatorcontrib><title>Optimized double emulsion-solvent evaporation process for production of solid lipid nanoparticles containing baclofene as a lipid insoluble drug</title><title>Journal of drug delivery science and technology</title><description>Intrathecal injection of baclofen is the reference treatment for severe spasticity of cerebral-spinal origin. Solid lipid nanoparticles (SLNs) could be considered as a beneficial delivery system for enhancing penetration of drug through the blood brain barrier (BBB). In this study, baclofen- loaded SLNs were prepared using double emulsification-solvent evaporation method and a Box-Behnken design, based on three independent variables, was used to reduce the number of required experiments. Variable parameters were drug/lipid ratio, w/o phase ratio and the amount of surfactant. It was deduced that SLNs with small particle size, lipophilic feature, high entrapment efficiency and good loading capacity could be produced by this method and experimental design method could be useful for predicting optimum baclofen loaded SLNs with minimum numbers of experiments. Characterization of optimum formulation, provided by evaluation of experimental data, showed no significant difference between calculated and measured data.</description><subject>Baclofen</subject><subject>Double emulsion</subject><subject>Entrapment efficiency</subject><subject>Optimization</subject><subject>Solid lipid nanoparticles</subject><subject>solvent evaporation</subject><issn>1773-2247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFUMtqwzAQ9KGFhjSfUNAxPbjVw7LsUymhLwjk0NyFIq2Diiy5kh1ov6KfXMcJvfayuwwzs8xk2Q3BdwST8v6dCMFySguxJOyWY8yKXFxksz_4Kluk9IExJgKTgtaz7GfT9ba132CQCcPOAYJ2cMkGn6fgDuB7BAfVhaj6EUNdDBpSQk2Ix9sMeoJDg0a2NcjZbpxe-dCp2FvtICEdfK-st36Pdkq70IAHpBJSZ7b1o3Z6beKwv84uG-USLM57nm2fn7ar13y9eXlbPa5zzQra502NC2pKWpoGylprA5hQxWlV6V1ZU6UEOSbUTNC64kZxBqLBJeG8LAvQbJ4tT7Zjis8BUi9bmzQ4pzyEIUlSEMpJxTkdqfxE1TGkFKGRXbStil-SYHnsXU69y2PBkjA59S7FqHs46WCMcbAQZdIWvAZjI-hemmD_cfgFF_2Ppg</recordid><startdate>20130101</startdate><enddate>20130101</enddate><creator>Nabi-Meibodi, M.</creator><creator>Navidi, B.</creator><creator>Navidi, N.</creator><creator>Vatanara, A.</creator><creator>Reza Rouini, M.</creator><creator>Ramezani, V.</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20130101</creationdate><title>Optimized double emulsion-solvent evaporation process for production of solid lipid nanoparticles containing baclofene as a lipid insoluble drug</title><author>Nabi-Meibodi, M. ; Navidi, B. ; Navidi, N. ; Vatanara, A. ; Reza Rouini, M. ; Ramezani, V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342t-f9042d626dfe69ccde012a5288cb692aa710142c372985da53e7f06155664ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Baclofen</topic><topic>Double emulsion</topic><topic>Entrapment efficiency</topic><topic>Optimization</topic><topic>Solid lipid nanoparticles</topic><topic>solvent evaporation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nabi-Meibodi, M.</creatorcontrib><creatorcontrib>Navidi, B.</creatorcontrib><creatorcontrib>Navidi, N.</creatorcontrib><creatorcontrib>Vatanara, A.</creatorcontrib><creatorcontrib>Reza Rouini, M.</creatorcontrib><creatorcontrib>Ramezani, V.</creatorcontrib><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of drug delivery science and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nabi-Meibodi, M.</au><au>Navidi, B.</au><au>Navidi, N.</au><au>Vatanara, A.</au><au>Reza Rouini, M.</au><au>Ramezani, V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Optimized double emulsion-solvent evaporation process for production of solid lipid nanoparticles containing baclofene as a lipid insoluble drug</atitle><jtitle>Journal of drug delivery science and technology</jtitle><date>2013-01-01</date><risdate>2013</risdate><volume>23</volume><issue>3</issue><spage>225</spage><epage>230</epage><pages>225-230</pages><issn>1773-2247</issn><abstract>Intrathecal injection of baclofen is the reference treatment for severe spasticity of cerebral-spinal origin. Solid lipid nanoparticles (SLNs) could be considered as a beneficial delivery system for enhancing penetration of drug through the blood brain barrier (BBB). In this study, baclofen- loaded SLNs were prepared using double emulsification-solvent evaporation method and a Box-Behnken design, based on three independent variables, was used to reduce the number of required experiments. Variable parameters were drug/lipid ratio, w/o phase ratio and the amount of surfactant. It was deduced that SLNs with small particle size, lipophilic feature, high entrapment efficiency and good loading capacity could be produced by this method and experimental design method could be useful for predicting optimum baclofen loaded SLNs with minimum numbers of experiments. Characterization of optimum formulation, provided by evaluation of experimental data, showed no significant difference between calculated and measured data.</abstract><pub>Elsevier B.V</pub><doi>10.1016/S1773-2247(13)50034-7</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1773-2247 |
ispartof | Journal of drug delivery science and technology, 2013-01, Vol.23 (3), p.225-230 |
issn | 1773-2247 |
language | eng |
recordid | cdi_proquest_miscellaneous_1412518552 |
source | ScienceDirect Freedom Collection |
subjects | Baclofen Double emulsion Entrapment efficiency Optimization Solid lipid nanoparticles solvent evaporation |
title | Optimized double emulsion-solvent evaporation process for production of solid lipid nanoparticles containing baclofene as a lipid insoluble drug |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T02%3A41%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Optimized%20double%20emulsion-solvent%20evaporation%20process%20for%20production%20of%20solid%20lipid%20nanoparticles%20containing%20baclofene%20as%20a%20lipid%20insoluble%20drug&rft.jtitle=Journal%20of%20drug%20delivery%20science%20and%20technology&rft.au=Nabi-Meibodi,%20M.&rft.date=2013-01-01&rft.volume=23&rft.issue=3&rft.spage=225&rft.epage=230&rft.pages=225-230&rft.issn=1773-2247&rft_id=info:doi/10.1016/S1773-2247(13)50034-7&rft_dat=%3Cproquest_cross%3E1412518552%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c342t-f9042d626dfe69ccde012a5288cb692aa710142c372985da53e7f06155664ec3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1412518552&rft_id=info:pmid/&rfr_iscdi=true |